List of Tables
Table 1. Global Somatostatin Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Somatostatin Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Somatostatin Market Competitive Situation by Manufacturers in 2025
Table 4. Global Somatostatin Sales (K Pcs) of Key Manufacturers (2021–2026)
Table 5. Global Somatostatin Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Somatostatin Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Somatostatin Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Somatostatin Average Price (USD/Pcs) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Somatostatin, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Somatostatin, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Somatostatin, Product Types and Applications
Table 12. Global Key Manufacturers of Somatostatin, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Somatostatin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Somatostatin Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Somatostatin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Somatostatin Sales by Region (K Pcs), 2021–2026
Table 18. Global Somatostatin Sales Market Share by Region (2021–2026)
Table 19. Global Somatostatin Sales by Region (K Pcs), 2027–2032
Table 20. Global Somatostatin Sales Market Share by Region (2027–2032)
Table 21. Global Somatostatin Revenue by Region (US$ Million), 2021–2026
Table 22. Global Somatostatin Revenue Market Share by Region (2021–2026)
Table 23. Global Somatostatin Revenue by Region (US$ Million), 2027–2032
Table 24. Global Somatostatin Revenue Market Share by Region (2027–2032)
Table 25. North America Somatostatin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Somatostatin Sales by Country (K Pcs), 2021–2026
Table 27. North America Somatostatin Sales by Country (K Pcs), 2027–2032
Table 28. North America Somatostatin Revenue by Country (US$ Million), 2021–2026
Table 29. North America Somatostatin Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Somatostatin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Somatostatin Sales by Country (K Pcs), 2021–2026
Table 32. Europe Somatostatin Sales by Country (K Pcs), 2027–2032
Table 33. Europe Somatostatin Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Somatostatin Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Somatostatin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Somatostatin Sales by Region (K Pcs), 2021–2026
Table 37. Asia Pacific Somatostatin Sales by Region (K Pcs), 2027–2032
Table 38. Asia Pacific Somatostatin Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Somatostatin Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Somatostatin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Somatostatin Sales by Country (K Pcs), 2021–2026
Table 42. Latin America Somatostatin Sales by Country (K Pcs), 2027–2032
Table 43. Latin America Somatostatin Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Somatostatin Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Somatostatin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Somatostatin Sales by Country (K Pcs), 2021–2026
Table 47. Middle East and Africa Somatostatin Sales by Country (K Pcs), 2027–2032
Table 48. Middle East and Africa Somatostatin Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Somatostatin Revenue by Country (US$ Million), 2027–2032
Table 50. Global Somatostatin Sales (K Pcs) by Type (2021–2026)
Table 51. Global Somatostatin Sales (K Pcs) by Type (2027–2032)
Table 52. Global Somatostatin Sales Market Share by Type (2021–2026)
Table 53. Global Somatostatin Sales Market Share by Type (2027–2032)
Table 54. Global Somatostatin Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Somatostatin Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Somatostatin Revenue Market Share by Type (2021–2026)
Table 57. Global Somatostatin Revenue Market Share by Type (2027–2032)
Table 58. Global Somatostatin Price (USD/Pcs) by Type (2021–2026)
Table 59. Global Somatostatin Price (USD/Pcs) by Type (2027–2032)
Table 60. Global Somatostatin Sales (K Pcs) by Application (2021–2026)
Table 61. Global Somatostatin Sales (K Pcs) by Application (2027–2032)
Table 62. Global Somatostatin Sales Market Share by Application (2021–2026)
Table 63. Global Somatostatin Sales Market Share by Application (2027–2032)
Table 64. Global Somatostatin Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Somatostatin Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Somatostatin Revenue Market Share by Application (2021–2026)
Table 67. Global Somatostatin Revenue Market Share by Application (2027–2032)
Table 68. Global Somatostatin Price (USD/Pcs) by Application (2021–2026)
Table 69. Global Somatostatin Price (USD/Pcs) by Application (2027–2032)
Table 70. Merck (Schweiz) AG Company Information
Table 71. Merck (Schweiz) AG Description and Business Overview
Table 72. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 73. Merck (Schweiz) AG Somatostatin Product
Table 74. Merck (Schweiz) AG Recent Developments/Updates
Table 75. SANOFI-AVENTIS FRANCE Company Information
Table 76. SANOFI-AVENTIS FRANCE Description and Business Overview
Table 77. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 78. SANOFI-AVENTIS FRANCE Somatostatin Product
Table 79. SANOFI-AVENTIS FRANCE Recent Developments/Updates
Table 80. Lyomark Pharma GmbH Company Information
Table 81. Lyomark Pharma GmbH Description and Business Overview
Table 82. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 83. Lyomark Pharma GmbH Somatostatin Product
Table 84. Lyomark Pharma GmbH Recent Developments/Updates
Table 85. ALFA WASSERMANN S.p.A. Company Information
Table 86. ALFA WASSERMANN S.p.A. Description and Business Overview
Table 87. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 88. ALFA WASSERMANN S.p.A. Somatostatin Product
Table 89. ALFA WASSERMANN S.p.A. Recent Developments/Updates
Table 90. Polypeptide Laboratories, Inc Company Information
Table 91. Polypeptide Laboratories, Inc Description and Business Overview
Table 92. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 93. Polypeptide Laboratories, Inc Somatostatin Product
Table 94. Polypeptide Laboratories, Inc Recent Developments/Updates
Table 95. SAMARTH Company Information
Table 96. SAMARTH Description and Business Overview
Table 97. SAMARTH Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 98. SAMARTH Somatostatin Product
Table 99. SAMARTH Recent Developments/Updates
Table 100. UBPL Company Information
Table 101. UBPL Description and Business Overview
Table 102. UBPL Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 103. UBPL Somatostatin Product
Table 104. UBPL Recent Developments/Updates
Table 105. HYBIO Company Information
Table 106. HYBIO Description and Business Overview
Table 107. HYBIO Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 108. HYBIO Somatostatin Product
Table 109. HYBIO Recent Developments/Updates
Table 110. TianTaiShan Company Information
Table 111. TianTaiShan Description and Business Overview
Table 112. TianTaiShan Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 113. TianTaiShan Somatostatin Product
Table 114. TianTaiShan Recent Developments/Updates
Table 115. Yangtze River Company Information
Table 116. Yangtze River Description and Business Overview
Table 117. Yangtze River Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 118. Yangtze River Somatostatin Product
Table 119. Yangtze River Recent Developments/Updates
Table 120. Siyao Company Information
Table 121. Siyao Description and Business Overview
Table 122. Siyao Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 123. Siyao Somatostatin Product
Table 124. Siyao Recent Developments/Updates
Table 125. Shuangcheng Company Information
Table 126. Shuangcheng Description and Business Overview
Table 127. Shuangcheng Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 128. Shuangcheng Somatostatin Product
Table 129. Shuangcheng Recent Developments/Updates
Table 130. Hainan Zhonghe Company Information
Table 131. Hainan Zhonghe Description and Business Overview
Table 132. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 133. Hainan Zhonghe Somatostatin Product
Table 134. Hainan Zhonghe Recent Developments/Updates
Table 135. SL PHARM Company Information
Table 136. SL PHARM Description and Business Overview
Table 137. SL PHARM Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 138. SL PHARM Somatostatin Product
Table 139. SL PHARM Recent Developments/Updates
Table 140. Wuhan Hualong Company Information
Table 141. Wuhan Hualong Description and Business Overview
Table 142. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 143. Wuhan Hualong Somatostatin Product
Table 144. Wuhan Hualong Recent Developments/Updates
Table 145. Qingdao Guoda Company Information
Table 146. Qingdao Guoda Description and Business Overview
Table 147. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 148. Qingdao Guoda Somatostatin Product
Table 149. Qingdao Guoda Recent Developments/Updates
Table 150. Chengdu Shengnuo Company Information
Table 151. Chengdu Shengnuo Description and Business Overview
Table 152. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 153. Chengdu Shengnuo Somatostatin Product
Table 154. Chengdu Shengnuo Recent Developments/Updates
Table 155. Longjin Company Information
Table 156. Longjin Description and Business Overview
Table 157. Longjin Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 158. Longjin Somatostatin Product
Table 159. Longjin Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Somatostatin Distributors List
Table 163. Somatostatin Customers List
Table 164. Somatostatin Market Trends
Table 165. Somatostatin Market Drivers
Table 166. Somatostatin Market Challenges
Table 167. Somatostatin Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Somatostatin
Figure 2. Global Somatostatin Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Somatostatin Market Share by Type: 2025 & 2032
Figure 4. 0.25mg/pcs Product Picture
Figure 5. 0.75mg/pcs Product Picture
Figure 6. 3mg/pcs Product Picture
Figure 7. Global Somatostatin Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Somatostatin Market Share by Application: 2025 & 2032
Figure 9. Hormonal Disorder
Figure 10. Oncology
Figure 11. Metabolic Disorder
Figure 12. Others
Figure 13. Global Somatostatin Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Somatostatin Market Size (US$ Million), 2021–2032
Figure 15. Global Somatostatin Sales (K Pcs), 2021–2032
Figure 16. Global Somatostatin Average Price (USD/Pcs), 2021–2032
Figure 17. Somatostatin Report Years Considered
Figure 18. Somatostatin Sales Share by Manufacturers in 2025
Figure 19. Global Somatostatin Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Somatostatin Players: Market Share by Revenue in Somatostatin in 2025
Figure 21. Somatostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Somatostatin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Somatostatin Sales Market Share by Country (2021–2032)
Figure 24. North America Somatostatin Revenue Market Share by Country (2021–2032)
Figure 25. U.S. Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Somatostatin Sales Market Share by Country (2021–2032)
Figure 28. Europe Somatostatin Revenue Market Share by Country (2021–2032)
Figure 29. Germany Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Somatostatin Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Somatostatin Revenue Market Share by Region (2021–2032)
Figure 36. China Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Indonesia Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Thailand Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Malaysia Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Somatostatin Sales Market Share by Country (2021–2032)
Figure 46. Latin America Somatostatin Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Somatostatin Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Somatostatin Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Somatostatin by Type (2021–2032)
Figure 56. Global Revenue Market Share of Somatostatin by Type (2021–2032)
Figure 57. Global Somatostatin Price (USD/Pcs) by Type (2021–2032)
Figure 58. Global Sales Market Share of Somatostatin by Application (2021–2032)
Figure 59. Global Revenue Market Share of Somatostatin by Application (2021–2032)
Figure 60. Global Somatostatin Price (USD/Pcs) by Application (2021–2032)
Figure 61. Somatostatin Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
